Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$5.8M
-42.0% from 2023
Prescriptions
17K
$333.50 per claim
Patients
2,467
2,162 prescribers
Total spending, 2024
$5.8M
$2,345.21 per patient
Medicare prescription drug plans paid $5.8M for Abacavir-Lamivudine in 2024, for 17,348 prescriptions and refills to 2,467 patients (down 42.0% from 2023). The average cost per claim was $333.50.
California had the highest Medicare cost for Abacavir-Lamivudine in 2024: $961K for 2,856 claims, followed by New York ($815K).
Mariam M Khambaty, infectious disease in Baltimore, MD, had the highest Medicare cost for Abacavir-Lamivudine in 2024: 108 claims costing $46K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mariam M Khambaty Baltimore, MD | Infectious Disease | 108 | 11 | $46K |
| Mark E Higgins San Francisco, CA | Internal Medicine | 62 | 12 | $37K |
| William Briggs |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,635 | 24,999 | 3,426 | $12.0M |
| 2023 | 2,329 | 20,191 | 2,890 | $10.0M |
| 2024 | 2,162 | 17,348 | 2,467 | $5.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Physician Assistant |
| 60 |
| Under 11 |
| $32K |
| Cynthia H Miller Albany, NY | Infectious Disease | 37 | Under 11 | $30K |
| Erin M Duhaime Dallas, TX | Physician Assistant | 54 | Under 11 | $30K |
| Judith A Lightfoot Stratford, NJ | Infectious Disease | 43 | Under 11 | $24K |
| Spartaco Bellomo Jersey City, NJ | Infectious Disease | 16 | Under 11 | $24K |
| Vonda L Blasick Harrisburg, PA | Nurse Practitioner | 35 | Under 11 | $24K |
| Barbara M Gripshover Cleveland, OH | Infectious Disease | 37 | Under 11 | $24K |
| Ardis A Moe Los Angeles, CA | Family Practice | 82 | Under 11 | $24K |
| Joseph C Gathe Jr. Houston, TX | Infectious Disease | 52 | Under 11 | $24K |
| Blake D Hatfield Dallas, TX | Internal Medicine | 46 | Under 11 | $22K |
| Virginia I Cafaro San Francisco, CA | Internal Medicine | 57 | 11 | $21K |
| Patrick A Ryscavage Baltimore, MD | Infectious Disease | 25 | Under 11 | $21K |
| Jill Frickenhaus New York, NY | Nurse Practitioner | 58 | Under 11 | $21K |
| Judith Lee Baltimore, MD | Nurse Practitioner | 26 | Under 11 | $21K |
| Jerry C Maliot University Park, FL | Internal Medicine | 14 | Under 11 | $21K |
| Robert T Higginson Jr. Richmond, VA | Physician Assistant | 22 | Under 11 | $21K |
| 1245200062 | Infectious Disease | 23 | Under 11 | $20K |
| Michael O Stuart Baton Rouge, LA | Internal Medicine | 70 | Under 11 | $20K |
| Bruce Hirsch Manhasset, NY | Infectious Disease | 27 | Under 11 | $20K |
| John R Nienow San Francisco, CA | Internal Medicine | 42 | Under 11 | $19K |
| John P Doweiko Boston, MA | Internal Medicine | 25 | Under 11 | $19K |
| Tammy R Jones Monroe, LA | Family Practice | 45 | Under 11 | $19K |
| Denese C Gomes Richmond, VA | Nurse Practitioner | 22 | Under 11 | $19K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Cipla USA, Inc. CIPLA.NS | 10,990 | $3.4M |
| Aurobindo Pharm AUROPHARMA.NS | 5,276 | $2.0M |
| Laurus Labs Lim LAURUSLABS.NS | 1,007 | $344K |
| Lupin Pharmaceu LUPIN.NS | 75 | $34K |